MUFG Securities Americas’s Charles River Laboratories CRL Stock Holding History

MUFG Securities Americas’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$235K	Buy	1,362 +36	+3%	+$6.67K	0.02%	481
2025 Q4	$265K	Sell	1,326 -1	-0.1%	-$181	0.02%	481
2025 Q3	$208K	Buy	1,327 +239	+22%	+$38K	0.01%	492
2025 Q2	$165K	Buy	1,088 +182	+20%	+$24.3K	0.01%	490
2025 Q1	$136K	Buy	906 +151	+20%	+$25.3K	0.02%	490
2024 Q4	$139K	Buy	+755	New	+$145K	0.02%	479

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MUFG Securities Americas's CRL Position: Q1 2026 in Review

MUFG Securities Americas increased its Charles River Laboratories (CRL) stake by 2.7% in Q1 2026, buying an estimated $6.67K and bringing the position to 1,362 shares worth $235K. The position accounts for 0.02% of the portfolio, ranked #481.

MUFG Securities Americas first reported a position in CRL in Q4 2024 and has held it in 6 quarters since. The position peaked at $265K in Q4 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

MUFG Securities Americas held 1,362 shares of Charles River Laboratories worth $235K as of Q1 2026.
MUFG Securities Americas bought 36 Charles River Laboratories shares in Q1 2026, an estimated $6.67K.
Charles River Laboratories made up 0.02% of MUFG Securities Americas's portfolio in Q1 2026, its #481 holding.
MUFG Securities Americas first reported a position in Charles River Laboratories in Q4 2024 and has held it in 6 quarters since.
MUFG Securities Americas's Charles River Laboratories position peaked at $265K in Q4 2025.
558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.